Vaccine Contract Manufacturing Market Research Report 2023-2028 | Industry Size, Share, Demand, CAGR Value, Company Analysis and Forecast

IMARC Group has recently released a new research study titled "Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Outlook: 

The global vaccine contract manufacturing market reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.8% during 2023-2028. Vaccine contract manufacturing represents the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous services, including pre-formulation work, formulation development, method development, stability studies, pre-clinical activities, registration batches, commercial manufacturing, etc. In addition to this, they offer expertise and innovative technologies to expand the production chain of pharmaceutical companies. Consequently, vaccine contract manufacturing is gaining extensive traction across the globe.

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/vaccine-contract-manufacturing-market/requestsample

Market Trends:

The growing incidences of infectious diseases, such as hepatitis B, malaria, meningitis, etc., are primarily augmenting the vaccine contract manufacturing market. Furthermore, the reduced development costs and complex production protocols are positively influencing the global market. Apart from this, the increasing consumer awareness towards vaccinations, as they play an essential role in improving human and veterinary health, minimizing the need for antibiotics, preventing diseases, etc., is acting as another significant growth-inducing factor.

Moreover, the rising integration of advanced technologies with contract manufacturing is bolstering the market growth. Besides this, the introduction of expression systems, including the EB66 and GPEx and cell culture media platforms, lack of skilled labor and equipment across countries, and extensive R&D activities are catalyzing the global market.

Additionally, the sudden outbreak of the COVID-19 pandemic has propelled vaccine developers to sign outsourcing agreements with CMOs to understand the complexity of capital requirements for production, which is also stimulating the market growth. In line with this, the escalating demand for immunization programs and inoculations and continuous improvements in the healthcare industry are expected to fuel the vaccine contract manufacturing market in the coming years.

Vaccine Contract Manufacturing Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:        

The competitive landscape of the global vaccine contract manufacturing market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Players Covered: 

• Ajinomoto Co. Inc.
• Albany Molecular Research Inc
• Catalent Inc
• Cobra Biologics Limited (Charles River Laboratories International Inc.)
• Cytovance Biologics Inc. (Hepalink USA Inc.)
• Fujifilm Holdings Corporation
• ICON plc
• IDT Biologika GmbH
• Lonza Group AG
• Merck KGaA
• Pharmaceutical Product Development LLC
• PRA Health Sciences Inc.

Explore Full Report Description At: https://www.imarcgroup.com/vaccine-contract-manufacturing-market

Report Segmentation:

The report has segmented the global vaccine contract manufacturing market on the basis of vaccine type, workflow, application and region.

Based on Vaccine Type:

• Attenuated
• Inactivated
• Subunit-based
• Toxoid-based
• DNA-based

Based on Workflow:

• Downstream
• Upstream

Based on Application:

• Human Use
• Veterinary

Geographical Analysis:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3872&flag=C

Key highlights of the report:               

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Industry Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Explore More Related Reports:

Poultry Vaccines Market Report: https://www.imarcgroup.com/poultry-vaccines-market

Hospital Acquired Disease Testing Market 2023-2028: https://www.imarcgroup.com/hospital-acquired-disease-testing-market

eClinical Solutions Market Report: https://www.imarcgroup.com/eclinical-solutions-market

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com

About Us                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.